Technologies

Home > Contract Research
Fusion of Technologies
Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan. The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus
Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus
Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies
R&D Organization

R&D Organization

Synthesis and Biotech groups

Pipeline

Pipeline

CCSB's new products

Synthesis

Synthesis

CCSB has a kilo-grade pilot plant to scale up lab process

Biotechnology

Biotechnology

Small molecule and peptide production